Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer

Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer

Bibliographic Details
Main Authors:	Yongxing Bao, Yang Wang, Zhouguang Hui
Format:	Article
Language:	English
Published:	Wiley 2022-11-01
Series:	Thoracic Cancer
Online Access:	https://doi.org/10.1111/1759-7714.14651

Similar Items

Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
by: Alessandro Rizzo
Published: (2022-11-01)

Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta‐analysis
by: Yongxing Bao, et al.
Published: (2022-09-01)

Factors affecting timing of surgery following neoadjuvant chemoradiation for esophageal cancer
by: Shannon J. Jiang, et al.
Published: (2023-12-01)

Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery
by: Xiaokun Li, et al.
Published: (2022-07-01)

Comment on “bronchus perforation by EZ-Blocker endobronchial blocker during esophageal resection after neoadjuvant chemoradiation”
by: Swapnil Y Parab
Published: (2019-12-01)

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
by: Hirsch Matani, et al.
Published: (2022-11-01)

Comments on “Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta‐analysis”
by: Yuk‐Ming Tsang, et al.
Published: (2022-12-01)

DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation
by: Catarina Macedo‐Silva, et al.
Published: (2023-04-01)

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
by: Richel DJ, et al.
Published: (2008-11-01)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
by: Chi Zhang, et al.
Published: (2023-01-01)

Locoregional recurrence and survival of breast−conserving surgery compared to mastectomy following neoadjuvant chemotherapy in operable breast cancer
by: Fa-you Lv, et al.
Published: (2024-03-01)

Neoadjuvant immunotherapy of locoregionally advanced solid tumors
by: John Wright, et al.
Published: (2022-08-01)

Neoadjuvant immunotherapy for resectable esophageal cancer: A review
by: Qing Li, et al.
Published: (2022-12-01)

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC
by: Christopher A. Lemmon, MD, et al.
Published: (2022-07-01)

Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now.
by: MacGregor, T, et al.
Published: (2012)

Sweet syndrome in a patient with rectal adenocarcinoma and HIV following neoadjuvant chemoradiation
by: Kamina Wilkerson, BS, et al.
Published: (2024-01-01)

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.
by: Tinkl, D, et al.
Published: (2009)

Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery
by: Yahang Liang, et al.
Published: (2024-03-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01)

Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
by: Jing Li, et al.
Published: (2023-01-01)

Neoadjuvant Chemotherapy-Chemoradiation for Borderline-Resectable Pancreatic Adenocarcinoma: A UK Tertiary Surgical Oncology Centre Series
by: Rachna Gorbudhun, et al.
Published: (2022-09-01)

Outcomes of Pulmonary Resection and Mediastinal Node Dissection by Video-Assisted Thoracoscopic Surgery Following Neoadjuvant Chemoradiation Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer
by: Yeong Jeong Jeon, et al.
Published: (2018-02-01)

Bilateral video-assisted thoracic surgery for esophageal cancer with left inferior pulmonary vein invasion following chemoradiation therapy
by: Masakazu Fujii, et al.
Published: (2023-07-01)

Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta‐analysis
by: Charles E. Gaber, et al.
Published: (2024-02-01)

Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis
by: Yunsong Liu, et al.
Published: (2023-01-01)

Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma?
by: Jun Wang, et al.
Published: (2022-11-01)

653 Neoadjuvant CAN-2409+Prodrug plus chemoradiation for borderline resectable or locally advanced non-metastatic pancreatic adenocarcinoma (PDAC)
by: Francesca Barone, et al.
Published: (2023-11-01)

Review for N2 Sub-staging in Non-small Cell Lung Cancer
by: Yongxing BAO, et al.
Published: (2022-12-01)

Neoadjuvant immunotherapy for resectable esophagal squamous cell carcinoma: An ace up the sleeve
by: Qing Zhou, et al.
Published: (2023-09-01)

Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
by: Ana Acuna-Villaorduna MD, et al.
Published: (2022-10-01)

Opportunities and limitations of CT - assessment of neoadjuvant chemoradiation therapy of gastric cancer
by: T. A. Agababyan, et al.
Published: (2019-12-01)

The long-term survival of the doublet regimen of concurrent chemoradiation therapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective study
by: Zhi-Qiang Wang, et al.
Published: (2022-11-01)

Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
by: Daoan Cheng, et al.
Published: (2023-02-01)

The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation
by: Yi Sun, et al.
Published: (2022-12-01)

Neoadjuvant Treatment Strategies for Resectable Proximal Gastric, Gastroesophageal Junction and Distal Esophageal Cancer
by: M. Usman Ahmad, et al.
Published: (2022-03-01)

The Effect of Neoadjuvant Therapy on Early Complications of Esophageal Cancer Surgery
by: Mohammadtaghi Rajabi Mashhadi, et al.
Published: (2015-07-01)

Neoadjuvant short-course radiotherapy or chemoradiation plus consolidative chemotherapy followed by radical operation for locally advanced rectal cancer
by: Shing Fung Lee, et al.
Published: (2024-01-01)

Prediction of pathologic complete response to neoadjuvant chemoradiation in locally advanced rectal cancer
by: Xiaoling Zhong, et al.
Published: (2024-03-01)

Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer
by: Delphine Dayde, et al.
Published: (2021-07-01)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
by: Oliver J. Ott, et al.
Published: (2021-03-01)